02607 SH PHARMA
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.36X | Oper Margin | 3.3% |
|---|---|---|---|
| LT Debt/Equity | 13.6% | Net Margin | 1.7% |
| Total Debt/Equity | 66.7% | Return on Equity | 6.4% |
| Price/Book | 0.62X | Return on Assets | 2.1% |
| (HKD 12.660) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 4,841.61 | 4,153.09 | 6,297.95 | 6,229.82 | 5,336.11 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +16.6 | -34.1 | +1.1 | +16.8 | +17.0 |
| Earnings Per Share (HKD) | 1.307 | 1.122 | 1.808 | 2.192 | 1.878 |
| Earnings Per Share Growth (%) | +16.5 | -38.0 | -17.5 | +16.8 | +17.0 |
| Dividend Per Share (HKD) | 0.404 | 0.441 | 0.664 | 0.492 | 0.576 |
| P/E* (X) | 9.69 | 11.28 | 7.00 | 5.78 | 6.74 |
| Yield (%) | 3.19 | 3.48 | 5.24 | 3.89 | 4.55 |
| Dividend Share (%) | 30.93 | 39.27 | 36.71 | 22.45 | 30.69 |
| Book NAV (HKD) | 20.558 | 20.395 | 20.335 | 21.242 | 18.939 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2025-03 | 2024-03 | Chg* (%) | 2023-03 |
| Cover Period (mths) | 3 | 3 | NA | 3 |
|---|---|---|---|---|
| Turnover | 70,763 | 70,153 | +0.9 | 66,226 |
| Operating Result | 1,931 | 2,101 | -8.1 | 2,267 |
| Associates | 215.829 | 203.279 | +6.2 | 201.684 |
| Profit Before Taxation | 2,153 | 2,417 | -10.9 | 2,492 |
| Taxation | 512.524 | 551.128 | -7.0 | 538.851 |
| Profit /( Loss) After Taxation | 1,640 | 1,866 | -12.1 | 1,953 |
| Minority Interests | 307.123 | 323.295 | -5.0 | 435.396 |
| Net Profit | 1,333 | 1,542 | -13.6 | 1,518 |
| Earnings Per Share () | 0.3862 | 0.4549 | -15.1 | 0.4686 |
| Announcement Date | 2025-04-28 | 2024-04-26 | NA | 2023-04-26 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
